IL2 and lung carcinoma: For example, they showed that sera from lung cancer patients down-regulated interleukin-2 receptor subunit alpha (IL-2Rα) gene expression and inhibited interleukin-1 beta (IL-1B) and IL-2 release in concanavalin A-stimulated PBMCs from healthy donors compared to the sera from normal controls35.